During the past decade, Heart Health Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Heart Health Institute" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Heart Health Institute" are "Heart Failure" (2 trials), "ASCVD" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Coronary Stenosis" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Heart Health Institute" in a lesser frequency.

Most popular intervention types in "Heart Health Institute" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (3 trials), "Evolocumab" (1 trials) and "Ringer Perfusion Balloon Catheter" (1 trials). Other intervention names were less common.

The vast majority of trials in "Heart Health Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Heart Health Institute". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Heart Health Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Heart Health Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".